Medical devices and instrumentation

Finding promise in innovation, demand, and emerging markets.

Unprecedented challenges face today's highly diversified medical device industry:

• Emerging-market risk
• Escalating global healthcare costs
• Rapid technology advances
• Increasing pressure on start-up financing

Challenges compounded

Adding to these challenges, heightened sensitivity to cost, safety and quality and more engaged consumers demand the industry's attention while it struggles to meet growing regulatory demands. Simultaneously, increased requirements for comparative research and outcomes data force clinical trials to grow in length, size and complexity.

Dwindling financial resources combined with these market forces threaten the industry's sustainability. Initial public offerings are few and far between, and a lackluster M&A environment holds little promise of a stable future as device companies attempt to cut costs and manage finances in a down economy.

Relationships between physicians and sales people, increasingly important for product development, remain under the regulatory microscope.

Future holds promise

Despite these continuing challenges, growth opportunities lie in:

• Increased innovation
• Heightened demand for medical technology
• Emerging-market expansion

How we can help

Our tailored suite of medical device industry services can help you meet the challenges of today and tomorrow. We offer a broad array of quality and supply chain management solutions. We help companies develop and execute enterprise transformation programs to balance the cost-risk equation by consolidating similar, non-differentiating business processes into shared services. We also help medical device companies take advantage of low-cost locations for manufacturing and carefully assess and mitigate emerging-market risks.

Our proven methods also help medical device companies:

• Integrate innovation and compliance into research and development processes and business operations
• Develop a clinical trial strategy that relies on outcomes data analysis to prove therapeutic value
• Foster mutually beneficial relationships with payers, physicians, researchers, and patients through open innovation